SEB Concept Biotechnology - Klasse D (EUR)
LU0118405827
SEB Concept Biotechnology - Klasse D (EUR)/ LU0118405827 /
| NAV20/06/2024 |
Diferencia+0.8540 |
Tipo de beneficio |
Enfoque de la inversión |
Sociedad de fondos |
| 109.3330EUR |
+0.79% |
paying dividend |
Equity
Worldwide
|
SEB IM ▶ |
Estrategia de inversión
The fund aims to increase the value of your investment over time and to outperform its benchmark.
The fund is actively managed and invests in stocks globally, primarily in the biotech sector. Investment decisions are based on in-depth (fundamental) analysis. The focus is on companies' business models, earning capacity, management and market positions. The return is determined by how much the fund's holdings increase or decrease in value during your holding period.
Objetivo de inversión
The fund aims to increase the value of your investment over time and to outperform its benchmark.
Datos maestros
| Tipo de beneficio: |
paying dividend |
| Categoría de fondos: |
Equity |
| Región: |
Worldwide |
| Sucursal: |
Sector Biotechnology |
| Punto de referencia: |
Nasdaq Biotechnology Index |
| Inicio del año fiscal: |
01/01 |
| Última distribución: |
23/05/2024 |
| Banco depositario: |
Skandinaviska Enskilda Banken AB, Lux |
| País de origen: |
Luxembourg |
| Permiso de distribución: |
Germany, Luxembourg |
| Gestor de fondo: |
Angelica Fatouros |
| Volumen de fondo: |
138.48 millones
EUR
|
| Fecha de fundación: |
16/10/2000 |
| Enfoque de la inversión: |
- |
Condiciones
| Recargo de emisión: |
0.00% |
| Max. Comisión de administración: |
1.50% |
| Inversión mínima: |
- EUR |
| Deposit fees: |
- |
| Cargo por amortización: |
0.00% |
| Prospecto simplificado: |
Descargar (Versión para imprimir) |
Sociedad de fondos
| Fondos de empresa: |
SEB IM |
| Dirección: |
Stephanstraße 14 - 16, 60313, Frankfurt am Main |
| País: |
Germany |
| Internet: |
seb.de/asset-management
|
Países
| United States of America |
|
77.06% |
| United Kingdom |
|
7.34% |
| Sweden |
|
4.19% |
| Netherlands |
|
2.32% |
| Cash |
|
2.25% |
| Denmark |
|
2.24% |
| Ireland |
|
1.51% |
| Bermuda |
|
1.37% |
| Canada |
|
1.02% |
| Cayman Islands |
|
0.70% |
Sucursales
| Pharma/Biotechnology |
|
91.82% |
| Healthcare services |
|
3.63% |
| Healthcare appliances |
|
2.30% |
| Cash |
|
2.25% |
